Cytotoxic effect of immunoconjugate composed of glucose-oxidase coupled to an anti-ganglioside (GD2) antibody on spheroids.
Anticancer Res
; 17(4B): 3177-8, 1997.
Article
en En
| MEDLINE
| ID: mdl-9329630
ABSTRACT
As a new treatment protocol for neuroblastoma, the chimeric (human/mouse) antiganglioside GD2 antibody chl4.18 is being clinically tested. To improve the therapeutic effect of the antibody alone, we are currently investigating the cytotoxicity of glucose-oxidase coupled to the antibody chl4.18 on spheroids of the neuroblastoma cell line SK-N-LO. The cytotoxic effect of glucose-oxidase is achieved by the production of hydrogenperoxide (H2O2) and probably by the following reaction of H2O2 with iron to form hydrogen radicals (OH.). The cytotoxicity of glucose-oxidase was measured by two viability tests (MTT and WST 1). After a 4 hour treatment of the spheroids with the immunoconjugate, a reduction of viability to 50% (MTT-test) and 25% (WST 1-test), respectively, was obtained. The difference between the results of these two tests, might be explained by the different measurement protocols.
Search on Google
Banco de datos:
MEDLINE
Asunto principal:
Inmunoconjugados
/
Gangliósidos
/
Glucosa Oxidasa
/
Anticuerpos Monoclonales
/
Neuroblastoma
Tipo de estudio:
Guideline
Límite:
Humans
Idioma:
En
Año:
1997
Tipo del documento:
Article